Skip to main content

Page of 3
and
  1. No Access

    Reference Work Entry In depth

    Thiazolidin

    Bingliang Fang in Encyclopedia of Cancer (2017)

  2. Article

    Open Access

    TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

    Expression of the TUSC2/FUS1 tumor suppressor gene in TUSC2 deficient EGFR wildtype lung cancer cells increased sensitivity to erlotinib. Microarray mRNA expression analysis of TUSC2 inducible lung cancer cell...

    Cao **aobo, Mourad Majidi, Meng Feng, Ru** Shao, **g Wang in Scientific Reports (2016)

  3. Article

    Open Access

    Predictive biomarkers in precision medicine and drug development against lung cancer

    The molecular characterization of various cancers has shown that cancers with the same origins, histopathologic diagnoses, and clinical stages can be highly heterogeneous in their genetic and epigenetic altera...

    Bingliang Fang, Reza J Mehran, John V Heymach in Chinese Journal of Cancer (2015)

  4. No Access

    Living Reference Work Entry In depth

    Thiazolidin

    Bingliang Fang in Encyclopedia of Cancer

  5. Article

    Open Access

    Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer

    Elafin is an elastase-specific inhibitor with increased transcription in normal mammary epithelial cells compared to mammary carcinoma cells. In this report, we test the hypothesis that inhibition of elastase,...

    Kelly K Hunt, Hannah Wingate, Tomoya Yokota, Yanna Liu in Breast Cancer Research (2013)

  6. Article

    Open Access

    Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter

    The objective of this study was to evaluate the anti-tumor effects of Ad/gTRAIL (an adenoviral vector in which expression of GFP and TRAIL is driven by a human telomerase reverse transcriptase promoter, hTERT)...

    Jessica T Li, Ka Bian, Alan L Zhang, Dong H Kim in Cancer Cell International (2011)

  7. No Access

    Article

    α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivation

    Patients with glioblastomas, the most common primary tumors of the central nervous system, have poor prognoses because of uncontrolled tumor cell invasion and proliferation. β-Catenin plays an important role i...

    Haitao Ji, Ji Wang, Bingliang Fang, Xuexun Fang, Zhimin Lu in Journal of Neuro-Oncology (2011)

  8. No Access

    Reference Work Entry In depth

    Thiazolidin

    Bingliang Fang in Encyclopedia of Cancer (2011)

  9. Article

    Open Access

    Oxidative stress in NSC-741909-induced apoptosis of cancer cells

    NSC-741909 is a novel anticancer agent that can effectively suppress the growth of several cell lines derived from lung, colon, breast, ovarian, and kidney cancers. We recently showed that NSC-741909-induced a...

    **aoli Wei, Wei Guo, Shuhong Wu, Li Wang, Peng Huang in Journal of Translational Medicine (2010)

  10. No Access

    Reference Work Entry In depth

    Thiazolidin

    Bingliang Fang in Encyclopedia of Cancer (2009)

  11. No Access

    Article

    Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors

    Proteasome inhibitors have emerged as promising anticancer therapeutic agents. Bortezomib (PS-341), a specific proteasome inhibitor, exhibits antitumor activity against a wide range of malignancies and has bee...

    Hongbo Zhu, Lidong Zhang, Fengqin Dong, Wei Guo, Shuhong Wu, Fuminori Teraishi in Oncogene (2005)

  12. No Access

    Article

    Mechanisms of resistance to TRAIL-induced apoptosis in cancer

    The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is regarded as a potential anticancer agent. However, considerable numbers of cancer cells, especially some highly malignant tumors, are resi...

    Lidong Zhang, Bingliang Fang in Cancer Gene Therapy (2005)

  13. No Access

    Article

    Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter

    Local and locoregional administration of adenovectors expressing the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene has been demonstrated to be useful in treating established tumors in anima...

    Dietmar Jacob, John J Davis, Lidong Zhang, Hongbo Zhu in Cancer Gene Therapy (2005)

  14. No Access

    Article

    Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK

    We recently found that a small molecule 2[[3-(2,3-dichlorophenoxy)propyl]amino]ethanol (2,3-DCPE) could induce apoptosis and downregulate Bcl-XL expression in various cancer cells. Here, we found that 2,3-DCPE...

    Hongbo Zhu, Lidong Zhang, Shuhong Wu, Fuminori Teraishi, John J Davis in Oncogene (2004)

  15. No Access

    Article

    GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells

    The utility of dominant acting proapoptotic molecules to induce cell death in cancer cells is being evaluated in preclinical studies and clinical trials. We recently developed a binary adenoviral expression sy...

    Tsuyoshi Honda, Simona Coppola, Lina Ghibelli, Song H Cho in Cancer Gene Therapy (2004)

  16. No Access

    Article

    Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis

    The p53 gene is the most frequently mutated gene in human cancers. Loss of functional p53 leads to impaired responses of cancer cells to apoptosis induction and to poor prognosis in patients with certain types of...

    Jian Gu, Lidong Zhang, Stephen G Swisher, **song Liu, Jack A Roth in Oncogene (2004)

  17. No Access

    Article

    Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer

    To examine the role of H-ras in the development of human ovarian cancer, we used small inhibitory RNA (siRNA) to silence its expression in human ovarian cancer cell lines and assessed the effects of its silencing...

    Gong Yang, Jennifer Anne Thompson, Bingliang Fang, **song Liu in Oncogene (2003)

  18. No Access

    Article

    Long-term tumor-free survival from treatment with the GFP–TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells

    We evaluated anti-tumor activity and toxic effect of an adenoviral vector expressing the GFP/TRAIL fusion gene from the hTERT promoter (designated Ad/gTRAIL) on human breast cancer cell lines and on normal hum...

    Tongyu Lin, Xuefeng Huang, Jian Gu, Lidong Zhang, Jack A Roth, Momiao **ong in Oncogene (2002)

  19. No Access

    Article

    A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo

    Using a binary adenoviral system, we recently showed that the human telomerase reverse transcriptase (hTERT) promoter induces tumor-specific Bax gene expression. However, the strong cytotoxicity of Bax and other ...

    Jian Gu, Lidong Zhang, Xuefeng Huang, Tongyu Lin, Min Yin, Kai Xu, Lin Ji in Oncogene (2002)

  20. No Access

    Article

    Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences

    Our previous studies showed that the urokinase-type plasminogen activator receptor (uPAR) and the p16 tumor suppressor gene play a significant role in glioma invasion. We expected that downregulation of uPAR a...

    Yoshiaki Adachi, Nirmala Chandrasekar, Yoshiaki Kin, Sajani S Lakka in Oncogene (2002)

Page of 3